For the active substances azadirachtin, bupirimate, dithianon, hexythiazox, isoxaben, lime sulphur, orange oil, quinmerac, sodium silver thiosulfate, tau-fluvalinate, tebufenozide, tembotrione and zinc phosphide, the risk assessment pursuant to Article 11 of Implementing Regulation (EU) No 844/2012 has not yet been finalised by the respective rapporteur Member States.
Recital 5, Regulation (EU) 2024/1206
In forcesince 29 Apr 2024
- celex=32012R0844